Now showing 1 - 4 of 4
  • Publication
    The Longevity Landscape: Value Creation for Healthy Aging
    ( 2024-05-28) ;
    Odile-Florence Giger
    ;
    Elgar Fleisch
    ;
    Tobias Kowatsch
    ;
    Mia Jovanova
  • Publication
    Scalable Business Models in Digital Healthy Longevity: Lessons from Top-Funded Digital Health Companies in 2022
    Digital health companies can address significant healthcare challenges and mitigate the demographic impact on the health system. Healthcare value delivery becomes increasingly complex based on multiple health problems, different treatment methods and payment schemes, various care methods, and payment schemes; therefore, scaling up a healthcare solution is not trivial, especially for new companies. To explore the business models of the top-funded digital health companies and analyze the respective scalable element of their value creation and delivery processes, this study systematically used venture databases and a business model framework to describe top-funded companies. Then, we performed literature and desk research to specify which business model elements helped them scale up. As a result, we identified ten top-funded companies in the field; our main findings suggest that these companies scaled up by developing a platform for a wide range of users, in contrast to specific demogra phy and disease. We recommend that new digital companies in healthy longevity prioritize employers in customer acquisition and align incentives between patients and payers with the help of digital health data to improve transparency on return on investment.
    Type:
    Journal:
  • Publication
    Reimagining Preventive Care and Digital Health: A Paradigm Shift in a Health Insurance's Role
    (SciTePress, 2024) ;
    Kramer, Jan-Niklas
    ;
    Amidst non-communicable diseases' substantial health and economic burdens, health insurance companies and digital health technologies (DHTs) are increasingly crucial in enabling preventive care and minimizing global health expenditure. This position paper explores the perspective of an innovation manager of a Swiss health insurer. The interview transcript was analyzed using thematic analysis. The results highlight the importance of current regulations, the future role of health insurance companies, and the potential of DHTs to promote preventive care and business model innovation.
    Type:
    Journal:
    Volume:
  • Publication
    Collaboration and Innovation Patterns in Diabetes Ecosystems
    ( 2024)
    Odile-Florence Giger
    ;
    Estelle Pfitzer
    ;
    ;
    Hannes Gebhardt
    ;
    Elgar Fleisch
    ;
    Mia Jovanova
    ;
    Background: The global prevalence of diabetes is increasing and has stimulated new tech-nological advancements in disease management. Although there are many digital health companies with a focus on diabetes, building them up at scale is difficult due to a hetero-geneous, inefficient, and fragmented healthcare system. While ecosystems, or collaborative value creation, could help address system fragmentation; the current diabetes ecosystem remains not fully understood. Therefore, this paper analyzes the digital transformation of the diabetes ecosystem and deducts innovation patterns. We address the following research questions: (1) What are emerging organizations in the current diabetes ecosystem? (2) What are the value streams in the current diabetes ecosystem? (3) Which innovation patterns are present in the ecosystem? Methods: We conduct a literature review and a market analysis to describe the organiza-tions and value streams in the diabetes ecosystem, both before and after the digital trans-formation. We visualize the diabetes ecosystem using the e3-value methodology (RQ1 and RQ2). Next, expert interviews are conducted to validate the resulting diabetes ecosystem and deduce innovation patterns (RQ3). Results: First, we show that the digital transformation gives rise to emerging organizations across eight segments: real-world evidence analytics, healthcare management platforms, clinical decision support, diagnostic and monitoring, digital therapeutics, wellness, online community, online pharmacy (RQ1). Secondly, we visualize the value streams between emerging organizations in the current diabetes ecosystem, highlighting the key role of pa-tient data as currency (RQ2). Ultimately, we derive four innovation patterns in the current diabetes ecosystem (RQ3); namely open ecosystem strategy, outcome-based payments, plat-formization (connecting stakeholders), and user-centric software. Conclusions: We demonstrate how traditional value chains in the diabetes ecosystem tran-sition to platforms and outcome-based payment models, guiding strategic decisions for companies and healthcare providers. These innovation patterns may apply to similar eco-systems in other disease areas, aiding organizations in forecasting future dynamics.